Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04366466
Other study ID # 10477M-PEPS
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2020
Est. completion date September 2021

Study information

Verified date April 2020
Source Centre hospitalier de Ville-Evrard, France
Contact Youcef BENCHERIF
Phone 01.43.09.32.32
Email y.bencherif@epsve.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In France, the number of emergency visits for suicide attempts is estimated at 220,000 per year. Suicide management aims to reduce suicide risk factors in order to improve the mental health of patients and prevent recurrences.

To day, no study has compared the approaches to health surveillance and case management in a clinical trial, nor established the benefit of each on commitment to care and beyond the prevention of suicidal recurrence.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 138
Est. completion date September 2021
Est. primary completion date August 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age =18.

- Male and female.

- Admission to CH St Denis for a suicide attempt.

- Referral for outpatient follow-up.

- Patient with no psychiatric follow-up or who has been out of follow-up for at least three months.

- Patient having given their written informed consent.

Exclusion Criteria:

- Patients not affiliated with social security or state medical aid.

- Patients who do not have the required faculties to be evaluated (cognitive and delusional disorders).

- Patients treated for more than 72 hours after their procedure (maximum length of stay in the UAS and/or in medical intensive care.

- Patient currently under psychiatric care.

- Patients who cannot be called back by telephone (no telephone, homeless, incarceration).

- Patients who do not master the French language.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
suicide attempt patient using PEPS Program
The research protocol consists of two phases separated by randomization. A Hospital Phase common to both groups: Day zero is the day of the suicide attempt for which the patient came to the hospital. A post-hospital phase including the P.E.P.S. program for the intervention group and telephone reminders for the usual treatment group.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Januel

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders. Day 0
Primary Suicide Intent Scale The Suicide Intent Scale (SIS) developed by A.T. BECK in 1974, is the only scale that focuses solely on the assessment of the suicide attempt that has just taken place. Day 0
Primary Montgomery-Asberg depression rating scale This scale is widely used to measure the changes brought about by the treatment of depression. It assesses the severity of symptoms in a wide variety of areas such as mood, sleep and appetite, physical and mental fatigue, and thoughts of suicide. Day 0
Secondary Evaluating the effectiveness of the P.E.P.S. program in preventing suicidal recidivism percentage of all suicidants who relapse during the 12-month study period. 1 year
Secondary Evaluate the level of possible generalization of the program percentage of all suicides of subjects likely to benefit from the program (subjects fulfilling the inclusion and non-inclusion criteria). 1 year
Secondary Evaluate the feasibility of the program percentage of subjects included in the intervention group who received all interventions); weighted by the percentage of acceptance to participate in the study 1 year
See also
  Status Clinical Trial Phase
Completed NCT04127292 - Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Recruiting NCT05423483 - Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents Phase 2
Completed NCT03272048 - Identifying Effective Approaches to Counseling on Firearm Safety N/A
Completed NCT05514587 - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Enrolling by invitation NCT05639426 - Preventing Youth Violence Through Building Equitable Communities N/A
Completed NCT03703128 - Suicide in People Aged 45-60: A Case-control Psychological Autopsy Study
Completed NCT03646903 - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk N/A
Not yet recruiting NCT05558332 - Youth Nominated Support Team N/A
Not yet recruiting NCT06349915 - A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents N/A
Completed NCT02718248 - Ottawa Suicide Prevention in Men Pilot Study N/A
Completed NCT02094898 - Ketamine for Depression and Suicide Risk Phase 2
Completed NCT01360736 - A Brief Intervention to Reduce Suicide Risk in Military Service Members and Veterans - Study 2 (SAFEMIL) N/A
Completed NCT01594138 - Linguistic Characteristics of Suicidal Patients in the Emergency Department N/A
Completed NCT02228044 - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment N/A
Completed NCT00604097 - Preventing Youth Suicide in Primary Care: A Family Model Phase 3
Completed NCT00387855 - An Evaluation of the SOS (Suicide Prevention) Program N/A
Recruiting NCT03519802 - Evaluation of Cognitive Function in a Suicidal Crisis
Completed NCT05580757 - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting NCT03030924 - Wearable Suicidal Early Warning System for Adolescents